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COMMENTARY AND DEBATE
Preventing yellow fever epidemics in Asian megacities: how can cities control 
mosquito-transmitted diseases?
Fiona C. Shenton and Steve W. Lindsay
Department of Biosciences, Durham University, Durham, UK
ABSTRACT
The COVID-19 pandemic has reminded us of the ever present threat from infectious diseases, 
this includes the ones we know about already and future unknowns. The mosquito-transmitted 
disease yellow fever has claimed thousands of lives over the centuries and it hasn’t gone away. 
It is still endemic in tropical areas of Africa and Latin America, where it is kept at bay through 
constant surveillance, mass vaccination campaigns and some natural immunity within local 
populations. Despite this there are serious outbreaks from time to time. The Aedes mosquitoes 
capable of transmitting the virus from person to person, are now widespread in warmer 
countries worldwide, moreover they thrive in urban areas. With increased international move-
ment, the fear is that infected travellers could unwittingly introduce the virus into countries 
where people have little or no immunity. Densely populated Asian megacities are a major 
concern. There are simple measures citizens can take to protect themselves and their homes 
from the bite of infected mosquitoes, but city leaders must be at the forefront of a coordinated 
response bringing together diverse stakeholders to ensure a robust and sustainable defence.
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Large-scale outbreaks of new infectious diseases have 
occurred throughout human history, often with devastat-
ing consequences (McMichael 2001). What has changed 
is that they are occurring more frequently than before 
(Woolhouse et al. 2008). And, as shown by the world’s 
response to the COVID-19 pandemic, we are poorly 
prepared for large-scale disease outbreaks (Horton 
2020). Here we describe the potential threat posed by 
the mosquito-transmitted disease yellow fever. Yellow 
fever is not new, but there is a danger of it spreading 
into new areas, especially Asian cities. City leaders have 
an important part to play in mitigating against this peril.
Even within living memory (just) the present pan-
demic of COVID-19 is not unprecedented. In 1918 
‘Spanish’ flu caused the deaths of 17–50 million people 
(some put estimates even higher), far outstripping the 
numbers of young men killed in combat during World 
War 1 (Spinney 2017). More recently, the world has 
experienced epidemics of Human Immunodeficiency 
Virus/Acquired Immune Deficiency Syndrome (HIV/ 
AIDS) in 1981, Severe Acute Respiratory Syndrome 
(SARS) in 2002–2004, Swine flu (H1N1) 2009–2010, 
Middle East Respiratory Syndrome (MERS) in 
2012–2013 and Ebola from 2013–2016.
Of particular concern are those diseases transmitted 
by a common black and white urban mosquito, Aedes 
aegypti (Figure 1), probably found in every town and 
city throughout the tropics and sub-tropics. Aedes- 
transmitted diseases include dengue, chikungunya, 
Zika and yellow fever. Dengue, with the exception of 
COVID-19, is now the fastest growing infectious disease 
in the world. The number of global dengue cases has 
increased over eight fold within the last two decades, 
rising from 505,403 in 2000 to 4.2 million in 2019 (See 
https://www.who.int/news-room/fact-sheets/detail/den 
gue-and-severe-dengue, accessed 23/02/2021), demon-
strating the capacity of this mosquito to transmit 
viruses.
Yellow fever is the most deadly of the Aedes- 
transmitted diseases and, is presently found in tropical 
Africa and Latin America. The disease derives its name 
from the jaundice which develops in severe cases (See 
https://www.who.int/news-room/fact-sheets/detail/ 
yellow-fever, accessed 23/02/21). Symptoms appear 
rapidly, within three to six days, and include fever, 
muscle pain with prominent backache, headache, loss 
of appetite, and nausea or vomiting (Figure 2). Usually 
these symptoms disappear after a further three to four 
days, but a number of people enter a more dangerous 
phase of the disease. Within 24 hours of appearing to 
recover from the initial symptoms, the high fever 
returns and multiple body systems are affected, com-
monly the liver and kidneys. It is during this phase 
that patients develop jaundice and turn yellow. The 
liver damage also leads to dark urine, abdominal pain 
and vomiting. Bleeding can occur from the mouth, 
nose, eyes or stomach. Half of those who enter 
this second, distressing stage will die within 7–10 days.
Since many people are asymptomatic, the true case 
fatality rate (CFR) is difficult to determine, however, 
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for those who become sick, 20–60% die (Monath and 
Vasconelos 2015). At the end of the 19th century, 
when the United States invaded Cuba, for every sol-
dier who died in battle, 13 died of yellow fever (Bryan 
et al. 2004). This compares with the current estimate 
for the CFR from SARS-CoV-2 of about 1.4% in China 
(Verity et al. 2020).
Many of us are now familiar with the concept of the 
reproduction number (R0), the average number of sec-
ondary infections produced by a single infected person. 
Estimates of R0 in the case of mosquito-transmitted dis-
eases are trickier to estimate. An infectious mosquito may 
give rise to any number of infectious humans depending 
on the feeding rate, transmission efficiency, and how long 
the mosquito lives for. Nonetheless, for a pathogen, 
hitching a ride in an insect or tick can allow it to locate 
a host more easily and can therefore increase R0 by orders 
of magnitude compared with many directly transmitted 
diseases (Rogers and Packer 1993), like measles, mumps 
and COVID-19. A recent study suggested R0 could rise as 
high as 90 for yellow fever (Johansson et al. 2012). While 
the study authors thought that the R0 in most yellow fever 
epidemics would likely to be much lower, closer to 1; the 
potential for such high transmission is truly alarming, 
particularly in populations that are unvaccinated. Despite 
there being an extremely effective vaccine for yellow 
fever, large epidemics occur in heavily populated areas 
where people have little or no immunity, due to lack of 
vaccination.
The yellow fever mosquito, Ae. aegypti, was originally 
a tree-hole breeding mosquito found in the forests of 
West Africa. But, it has adapted to an urban existence 
by laying its eggs in small bodies of water such as collect in 
discarded containers, water containers, underground cul-
verts, guttering or old tyres. Towns and cities offer perfect 
habitats for this mosquito with a plethora of breeding 
sites and ready access to a human bloodmeal. In Asia, Ae. 
aegypti is now well-entrenched (Kraemer et al. 2019) and 
extremely capable of transmitting viruses, as shown by 
the rapidly increasing number of dengue cases in the 
region. Indeed dengue fever may be viewed as a useful 
proxy for identifying populations where yellow fever 
could be transmitted. Worryingly, we know from labora-
tory studies that Asian strains of Ae. aegypti can transmit 
yellow fever (Souza-Neto et al. 2019). Should that happen 
outside the laboratory, in densely populated Asian towns 
and cities where Aedes mosquitoes are abundant, 
Figure 1. Aedes aegypti, formerly known as the yellow fever 
mosquito. Centers for disease control and prevention public 
health image library https://phil.cdc.gov/details_linked.aspx? 
pid = 9261.
Figure 2. Symptoms of yellow fever.  
https://www.mxpharmacy.co.uk/uploads/4/1/5/5/41,550,283/yellow-fever-symptoms_orig.jpg
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the consequences would be catastrophic. The map in 
Figure 3 shows cities with populations over one million 
overlaid on the worldwide distribution of Ae. aegypti. 
Megacities clustering in India and China are of particular 
concern because populations here are neither naturally 
immune (having not been previously exposed to the 
virus) nor vaccinated. The drivers are 1. Presence of 
urban, human-biting mosquitoes, especially Aedes 
aegypti 2. Large non-immune, densely packed popula-
tions 3. Increased travel between countries where yellow 
fever is endemic and those large, non-immune urban 
populations. How can we protect Asian towns and cities 
from yellow fever? How do we do this in a megacity?
The drivers of yellow fever epidemics are urbaniza-
tion and rapid movement of people over great dis-
tances contributing to large urban outbreaks, notably 
in Angola in 2015 − 16 when the World Health 
Organisation (WHO) declared a global threat (See 
https://www.who.int/csr/don/22 March 2016-yellow- 
fever-angola/en/, accessed 23/02/2021). There was 
real fear that the disease might spill over into China. 
There were indeed confirmed reports of Chinese 
workers infected with yellow fever in Angola, return-
ing home to China. It was only a matter of great good 
fortune, that the disease did not spread from these 
individuals into the wider population, potentially 
1.8 billion mostly unvaccinated people in Asia 
(Wilder-Smith and Monath 2017). Projections show 
that another 2.5 billion people will be added to urban 
areas by 2050 (United Nations report, 2018 See https:// 
www.un.org/development/desa/en/news/population/ 
2018-world-urbanization-prospects.html, accessed 23/ 
02/2021), with approximately 90% of this increase 
occurring in Asia and Africa. Most of these countries 
do not vaccinate those at risk. Whilst WHO has an 
emergency stockpile of 18 million doses of yellow 
fever vaccine, world supplies are under pressure. In 
2015 − 2016, Angola was grappling with the worst 
yellow fever outbreak in decades (WHO.int). With 
the disease spreading to neighbouring countries, the 
death toll rising, and a shortage of vaccine, WHO 
agreed to the vaccine being used at a fractional dose 
as an interim measure in order to make supplies go 
further. This was a desperate state of affairs. In 
response to this threat, WHO (in partnership with 
UNICEF and Gavi) developed the Eliminate Yellow 
Fever Epidemics (EYE) Strategy 2017–2026. 
Worryingly, EYE Strategy implementation has been 
severely impacted by COVID-19, with all 2020 cam-
paigns postponed by several months (WHO Weekly 
epidemiological record No 34, 2020). Control of 
a recent (December 2020) outbreak of yellow fever in 
Nigeria has been hampered by the current focus on the 
COVID-19 pandemic response, and the relative proxi-
mity of the states affected to Lagos, an urban environ-
ment with a large unvaccinated population, is an 
added concern (See https://www.afro.who.int/news/ 
responding-yellow-fever-outbreak-nigeria-amidst- 
global-pandemic, accessed 23/02/2021)
Alongside measures more traditionally seen as 
‘health’ interventions such as vaccination, the EYE 
Strategy emphasises the importance of building resili-
ent urban centres. House improvements and good 
environmental management are integral to reducing 
disease transmission (Figure 4).
Keeping homes and their surroundings clear of rub-
bish reduces potential mosquito aquatic habitats. 
Underground water sources such as culverts, covered 
drains and soakaways, should be designed so as not to 
become mosquito breeding sites. Similarly a safe, reliable 
water supply without leaks and the need to store water in 
temporary containers; reduces the risk. Inside the house, 
simple improvements, including blocking of eaves, well- 
fitted doors and windows, and mosquito screening; can 
Figure 3. Cities and the distribution of the yellow fever mosquito. Predicted distribution of Aedes aegypti in 2015 (grey) and cities 
of over one million inhabitants (red). (Reproduced by kind permission of Dr Nick Golding, Curtin University, Perth, Australia).
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reduce mosquito entry and prevent indoor biting. At the 
same time it is important that houses remain well venti-
lated and cool so that inhabitants are comfortable 
indoors and will sleep under insecticide treated bednets 
where necessary. Based on the best evidence to date, we 
have recently drawn up recommendations, for simple 
steps to protect people from mosquitoes in and around 
their homes (Lindsay et al. 2021) (Figure 5).
While some of these measures (such as screening of 
windows and doors, and covering water containers) 
can be implemented by householders and commu-
nities themselves, it falls to city leaders to coordinate 
responses across communities and the wider popula-
tion. Essentially mosquito control is an environmental 
issue, requiring a multi-sectoral response. Box 1 lists 
Essential reading for those seeking in depth guidance 
on recommended interventions.
Community mobilisation to reduce sources of 
mosquitoes has been shown to be effective in 
a number of studies conducted in Central and 
South America, and Asia (Alvarado-Castro et al. 
2017). These community- based interventions were 
all carried out alongside the local authorities usual 
mosquito/disease control programmes, so the bene-
fits were additive. They are detailed and complex in 
their approach, first discussing the problem with 
stakeholders and involving them in the planning of 
interventions. Interventions commonly involve 
Figure 4. WHO recommendations for the control of the yellow fever mosquito.  
Adapted from Global vector control response 2017–2030: A strategic approach to tackle vector-borne diseases WHO/HTM/GVCR/2017.01 
https://apps.who.int/iris/bitstream/handle/10,665/259,002/WHO-HTM-GVCR-2017.01-eng.pdf;jsessionid = 0678B3844DED1434 
E47261C7745312CB?sequence = 1
Figure 5. The DELIVER mnemonic: our recommendations for protecting people from mosquitoes in and around their 
homes. https://doi.org/10.1098/rstb.2019.0814
Box 1. Essential reading.
1. Lindsay et al. (2021) Recommendations for building out mosquito-transmitted diseases in sub-Saharan Africa: the DELIVER mnemonic. Philosophical 
Transactions B 376(1818):20,190,814. DOI: https://doi.org/10.1098/rstb.2019.0814
A paper with specific recommendations for house and environmental improvements to protect people from mosquito bites.
2. World Health Organisation. Global Vector Control Response 2017–2030. Geneva: WHO; (2017), ISBN 978–92-4-151,297-8.
A really important document from the World Health Organisation describing in detail how to control disease vectors including mosquitoes.
3. Sim et al. (2020) A greener vision for vector control: The example of the Singapore dengue control programme. PLOS Neglected Tropical Diseases, 
14(8), e0008428 DOI: https://doi.org/10.1371/journal.pntd.0008428
Singapore as a unique exemplar of how a city coordintaes effective mosquito control through a multisectoral approach.
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community-based environmental management 
approaches such as provision of water container 
covers through community actors, clean-up cam-
paigns, and dissemination of dengue (or other mos-
quito-borne disease) information through 
schoolchildren or other groups. Importantly, they 
include working with providers of local services 
such as solid waste removal. The COVID-19 pan-
demic has highlighted the key role of city leaders in 
controlling disease outbreaks and maintaining 
essential services. Effective communication across 
sectors is required: health, mosquito control, hous-
ing, water & sanitation, and waste removal, and this 
must go alongside sound local knowledge of the 
situation on the ground.
Singapore’s impressive dengue control programme 
(Sim et al. 2020) is unique in bringing together all 
these elements, providing an exemplar of good prac-
tice. Although this programme predates WHO’s 
Global Vector Control Strategy (WHO, GVCR 
2017 − 2030) it aligns closely with the GVCR 
approach. With Singapore’s National Environment 
Agency at its heart, the programme focusses on 
reduction of Aedes mosquito aquatic habitats through 
multi-sectoral engagement bringing in both govern-
ment and nongovernment players along with com-
munities (Figure 6). There is great attention to detail: 
households are regularly inspected and householders 
can be fined for having open water containers, or 
allowing water to pool around house plants, accumu-
lated rubbish or other places. Roof gutters are banned 
and novel washing lines, constructed with holders 
which do not collect water, have been designed. 
Solid waste management is also an important ele-
ment, ensuring removal of artificial containers 
which could become habitats for Aedes mosquitoes. 
Approximately 60% of Singapore’s waste is recycled 
and the remainder incinerated. The ash generated by 
incineration is added to an artificial offshore island, 
Semakau Island, contributing to land reclamation.
In addition constant surveillance is essential with 
clear lines of communication to report problems, 
alongside well planned and practiced responses to 
contain increases in mosquito populations as soon as 
they arise. In order for cities to be able to take on 
these responsibilities, power must be devolved from 
central government to city leaders alongside the fis-
cal resources to support them.
Figure 6. Collaboration between Singapore’s national environment agency and other sectoral stakeholders. NGO, nongovern-
mental organisation. https://doi.org/10.1371/journal.pntd.0008428.g002
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The United Nations’ Sustainable Development 
Goals (SDGs) also emphasise the necessity for cross- 
sectoral collaboration. The SDGs of most relevance to 
combatting mosquito-transmitted diseases such as 
yellow fever are Goal 3: Good Health and Wellbeing, 
Goal 11: Sustainable Cities and Communities and 
Goal 17: Partnerships to achieve the Goals. These 
SDGs are the drivers underpinning the United 
Nations organisations recommendations on health, 
housing and resilience. For practitioners from the 
built environment the UN-Habitat’s ‘New Urban 
Agenda’ (UN, 2017 Habitat III Quito 
17–20 October 2016 https://habitat3.org/the-new- 
urban-agenda/) and the UN Office for Disaster Risk 
Making Cities Resilient Reduction’s ‘Making Cities 
Resilient 2030’ (See https://www.unisdr.org/cam 
paign/resilientcities/, accessed 23/02/2021) offer 
important guidance.
Summary
● Asia is home to cities with millions of people.
● The mosquito Aedes aegypti is abundant in cities 
and towns throughout the region. It is the world’s 
most efficient transmitter of arboviruses, including 
yellow fever which kills 20–60% of people who fall 
sick with the disease.
● Few people in Asia are vaccinated against yellow 
fever; while a very effective vaccine exists, supplies 
fall well short of what would be required to cover the 
total population potentially at risk.
● A yellow fever pandemic in an Asian city would 
claim 1,000s of lives.
● WHO recommends that mosquito populations 
should be controlled by combining good envir-
onmental management to reduce their aquatic 
habitats, with housing improvements to prevent 
mosquitoes entering dwelling places.
● Effective control relies on strong multi-sectoral 
collaboration with good communication between 
those in the health and built environment sectors.
● Power structures must be decentralised and 
authority devolved to city leaders alongside the 
necessary resources.
This approach has the added benefit of building resilience 
against all mosquito-transmitted diseases – including the 
new ones that we do not yet know about and for which we 
do not have treatments or vaccines. The Building Out 
Vector-borne diseases in sub-Saharan Africa (BOVA) 
Network (www.bovanetwork.org) is currently working 
in partnership with other organisations to support 
a network of Commonwealth city leaders to address 
vector-borne (especially mosquito-transmitted) and 
Neglected Tropical Disease (NTD) prevention in cities. 
As devastating as a yellow fever pandemic would certainly 
prove to be, it might not even be the worst we could 
encounter. Prevention must be the priority, not vain 
attempts to close the stable door once the horse has 
bolted.
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